SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000899140-16-001707
Filing Date
2016-11-30
Accepted
2016-11-30 15:31:22
Documents
1
Group Members
ALEXANDER J. DENNER, PH.D.SARISSA CAPITAL DOMESTIC FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, #7 s18770296.htm SC 13D/A 99448
  Complete submission text file 0000899140-16-001707.txt   101183
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 162025199
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A